MPS

Q1 FY27Printing & Publication

MPS Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹2,697

Market cap₹5.0K Cr

P/E27.1

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

2 of 4 strong

RevenueRank 3

MarginRank 3

CapexYes

FundraiseYes

Not discussed on this call: order book.

The short version

Corporate Learning expects continued growth with multiple enterprise engagements near $1 million and a strong pipeline of new clients, aiming for organic growth around 12%. FY’27 guidance expects to comfortably cross INR 300 crores in EBITDA, viewed as a floor rather than a ceiling.

From MPS's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3

Corporate Learning expects continued growth with multiple enterprise engagements near $1 million and a strong pipeline of new clients, aiming for organic growth around 12%.
Education segment grew 42.2% YoY, driven by strong AI-enabled content and new lanes like AI-generated content quality checks, with healthy pipeline and international expansion planned.
Research Solutions is growing steadily, with segment revenue up 13.2% YoY, focusing on AI-based knowledge solutions and integrity checks.
Unbound Medicine's recurring, high-renewal subscription model adds predictable revenue streams; expected to reach Rule of 40 (growth + EBITDA margin >40%) soon.
Overall company organic growth targeted in the late teens, outperforming market growth rates (Research ~15%, Education ~15%, Corporate Learning aims to catch up from current 6-7%).
FY’27 guidance is to comfortably cross INR 300 crore EBITDA with strong conviction, signaling confidence in growth and margin expansion.

Profitability & Margins

FY’27 guidance expects to comfortably cross INR 300 crores in EBITDA, viewed as a floor rather than a ceiling.
Three-year EBITDA CAGR projected at roughly 21% from FY’24 to FY’27.
FY’28 targets approximate INR 1,500 crores revenue and INR 450 crores EBITDA.
Q1 FY’27 is the strongest first quarter historically, with EBITDA margin expanding to 34.3%.
EPS for Q1 FY’27 at INR 29.70, up from INR 20.78 YoY.
Organic growth aspirations are higher than current early teens; aiming for late teens growth.
EBITDA margin improvements driven by AI-enabled and outcome-based revenue models.
Focus on operational leverage: revenue growth translating into margin expansion without significant headcount increases.
Unbound Medicine integration is expected to contribute to predictable and recurring revenue streams with improving margins.
Cash flow strong: INR 15-18 crores monthly, supporting acquisitions without equity dilution.

See what MPS said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

No explicit mention of current or planned capital expenditure (capex) in the provided transcript.
Focus appears to be on organic growth, AI integration, and strategic acquisitions rather than heavy capital investments.
Strategic investments focus on AI-enabled solutions, acquisitions of assets with existing strength, and expanding recurring revenue streams (e.g., Unbound Medicine).
Acquisition strategy targets companies with revenue above $15 million, mainly in education, science domains where AI acts as a multiplier.
Financing for acquisitions expected through internal cash accruals and debt (INR 300-500 crores range); minimal reliance on equity raising.
Continuous R&D investment in MPS Labs for AI and engineering indicated, supporting product and process innovation.
Overall, emphasis on leveraging AI for operating leverage and margin expansion rather than traditional large-scale capex.

Top-ranked in Printing & Publication

Ranked on what management guided this quarter

5x potential

1Dachepalli Pub.₹140 Cr

Rev 2Mar 3

2Chetana Educa.₹86 Cr

Rev 3Mar 1

3₹486 Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company prefers funding acquisitions through internal cash accruals and debt rather than equity.
Current cash accruals are about INR 15-18 crores per month (total around INR 138 crores).
Comfortable debt capacity is around INR 200 crores, allowing acquisition financing in the INR 300-500 crores range via cash plus debt.
Rahul Arora stated he does not foresee raising equity unless absolutely necessary but does not completely rule it out ("never say never").
The approach is to avoid equity raising due to its high cost to shareholders.
The company aims to balance cash flow and debt for acquisitions while maintaining financial discipline.

See what MPS said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from MPS Limited's Q1 FY’27 Earnings Call does not explicitly mention the current or expected order book or details about pending orders. However, relevant insights include: - The company has a healthy pipeline across its largest relationships, particularly in Education and Corporate Learning segments. - The opening quarter reflected strong business momentum with revenue and EBITDA growth suggesting ongoing and expected demand. - Emphasis is on expanding international knowledge organizations and growing existing accounts through cross-selling and AI platform enablement. - MPS focuses on outcome-based revenue models that contribute to recurring and deferred revenue streams. - The company aims for steady organic growth and selective acquisitions to build strategic assets, reflecting confidence in sustained order flow. - The work to deliver FY’27 targets is already in flight, indicating a robust backlog supporting guidance. No specific numerical order book or order backlog figures are disclosed in the call.

MPS — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹205 Cr, net profit ₹47 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What MPS Ltd's management said in earlier quarters

Others in Printing & Publication this season

S Chand & Company Ltd (Q1 FY27)
Student population increase of about 3%-4% per year. Key concall takeaways from S Chand & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector…
Dachepalli Publishers Ltd (Q1 FY27)
EPS showed growth from 4.03 to 4.21 in Q1 FY27, with PAT growing 42% YoY. Key concall takeaways from Dachepalli Pub.'s Q1 FY27 earnings call — and how it ranks…

Compare:vs S Chand & Company Ltd vs Repro India Ltd vs Dachepalli Publishers Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were MPS Q1 FY27 results?

What is MPS share price analysis?

MPS currently shows a below-average growth signal. The stock trades at a P/E of 27.1 with a market cap of ₹4,957 Cr. Investors should review the full earnings analysis for detailed insights.

Is MPS planning capital expenditure?

No explicit mention of current or planned capital expenditure (capex) in the provided transcript.

Keep MPS on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.